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Antiinflammatory and antileukemic-like activities 
of R01Yob, a medicinal plant of the rwandese
pharmacopeia
The identification of new compounds with potential
anticancer activity derived from herbaceous food or medicinal
plant extracts has been widely explored in recent years. Over
75% of the currently used anticancer agents are derived from
natural sources such as plants, marine organisms and
microorganisms (Tariq et al., 2017). However, only a small
portion of higher plants have been prospected for bioactive
compounds. Studies have already shown that cytotoxic
substances targeting cancer cells are good candidates for the
development of new anticancer drugs (Sriwiriyajan et al., 2014).
Therefore, further studies are needed to identify more efficient,
with less side effects, new compounds in cancer prevention and
treatment (Tomani et al., 2018).
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Fig, 2: Selective antileukemia-like activity of R01Yob extract. The plant extract has selectively shown strong time- and dose-dependent viability inhibition against
leukemic/lymphoma derived suspension cancer cells (jurkat, U-937, THP-1 and HL-60) but not normal peripheral blood monocytes (PBMC) and adherent cancer cells
(A549, HT-29, HCT-116, THP-1-derived macrophages).
Taken together, this study has shown that R01Yo could be a
potential source of anticancer drug. Its inhibitory effect on the
caspase-1 activity suggest that it could also be used in the
treatment of the inflammasome-caused diseases. Further
investigations are needed to characterize active molecules
and their mechanisms of action.
AIM OF THE STUDY
The present study aims at addressing at the molecular and
functional llevels the antiinflammatory and the antileukemic-like
activities of R01Yob, a plant of the rwandese pharmacopeia.
Fig.1: Inhibition of the caspase-1 activity by R01Yob extract. The plant extract
inhibited the inflammasome/caspase-1 activity in THP-1 derived macrophages.
However, the activity decreases due to the low solubility of the extract in water.
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The antiinflammatory activities of R01Yob extract was performed
using the Caspase-1 Glo assays (Promega) and the THP-1 cells.
At 25ug/ml the extract revealed inhibitory effect but this was lost
with higher doses, suggesting cell death leading to inflammation.
Test compounds
To investigate the influence of R01Yob extract on cell viability the Cell Titer Glo technology of Promega was employed using the indicated cells.
Results obtained show a strong reduction of the viability of suspension cancer cells but no effect on normal blood cells (PBMC) and adherent
cell lines.
